Studies in favor of using Hydroxychloroquine as an intervention to COVID-19
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
-
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
-
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
-
In vitro testing revealed synergistic effect of combined hydroxychloroquine (HCQ) and azithromycin (AZM) on SARS-CoV-2
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Learn After
French open-label non-randomized clinical trial in support of treating COVID-19 patients with HCQ
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
In vitro testing revealed synergistic effect of combined hydroxychloroquine (HCQ) and azithromycin (AZM) on SARS-CoV-2